1. Home
  2. IVA vs BHRB Comparison

IVA vs BHRB Comparison

Compare IVA & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • BHRB
  • Stock Information
  • Founded
  • IVA 2011
  • BHRB 1852
  • Country
  • IVA France
  • BHRB United States
  • Employees
  • IVA N/A
  • BHRB N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • BHRB Major Banks
  • Sector
  • IVA Health Care
  • BHRB Finance
  • Exchange
  • IVA Nasdaq
  • BHRB Nasdaq
  • Market Cap
  • IVA 769.0M
  • BHRB 907.7M
  • IPO Year
  • IVA 2020
  • BHRB N/A
  • Fundamental
  • Price
  • IVA $4.21
  • BHRB $60.20
  • Analyst Decision
  • IVA Strong Buy
  • BHRB Strong Buy
  • Analyst Count
  • IVA 8
  • BHRB 3
  • Target Price
  • IVA $16.13
  • BHRB $71.67
  • AVG Volume (30 Days)
  • IVA 492.4K
  • BHRB 45.4K
  • Earning Date
  • IVA 09-29-2025
  • BHRB 10-23-2025
  • Dividend Yield
  • IVA N/A
  • BHRB 3.67%
  • EPS Growth
  • IVA N/A
  • BHRB 264.64
  • EPS
  • IVA N/A
  • BHRB 7.05
  • Revenue
  • IVA $19,929,536.00
  • BHRB $331,643,000.00
  • Revenue This Year
  • IVA N/A
  • BHRB $51.05
  • Revenue Next Year
  • IVA N/A
  • BHRB $5.90
  • P/E Ratio
  • IVA N/A
  • BHRB $8.51
  • Revenue Growth
  • IVA N/A
  • BHRB 82.85
  • 52 Week Low
  • IVA $2.11
  • BHRB $47.57
  • 52 Week High
  • IVA $7.98
  • BHRB $72.68
  • Technical
  • Relative Strength Index (RSI)
  • IVA 44.77
  • BHRB 46.66
  • Support Level
  • IVA $3.55
  • BHRB $59.80
  • Resistance Level
  • IVA $4.10
  • BHRB $61.90
  • Average True Range (ATR)
  • IVA 0.28
  • BHRB 1.50
  • MACD
  • IVA 0.00
  • BHRB -0.00
  • Stochastic Oscillator
  • IVA 71.26
  • BHRB 39.14

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: